Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis
{{output}}
Background: Circulating tumor DNA (ctDNA) has emerged as a promising noninvasive biomarker for monitoring minimal residual disease (MRD) and predicting recurrence in early-stage breast cancer (EBC). Despite growing interest, the ... ...
